Skip to content
Dose Brief
Menu
No. 236 here · Grade C

Fifty 410 review

Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A.

Visit Fifty 410 Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.

On the record

The FDA issued a warning letter to Aspen Aesthetics dba Fifty 410 in February 2026. Fifty 410 keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.

Semaglutide
From $99/mo (all doses, compounded)
Tirzepatide
From $133/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Prices read from Fifty 410's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026. The published line reads From $99/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Fifty 410 scored on our six Brief Score factors. See the methodology.

Price Stability66/100
Supply Reliability73/100
Transparency72/100
Access Breadth50/100
Clinical Oversight80/100
Track Record46/100

What we like

  • Transparent public pricing from 99 dollars per month for semaglutide
  • No membership or subscription; pay only for what you need
  • Compounded by FDA-registered 503A and 503B pharmacies
  • Fast 24 to 48 hour provider review
  • Free one to two day shipping

The caveats

  • Does not bill insurance directly
  • Compounded GLP-1 is not an FDA-approved finished drug
  • Specific clinician credentials are not publicly disclosed
  • Served-states list is not published on the site
  • FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026; the letter is public in FDA's warning-letter database

The brief

Best for: Budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing. Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A.

Ranked #236 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Fifty 410.

Closest here

The providers scoring nearest Fifty 410 — the realistic shortlist if you're weighing it.

Weighing Fifty 410 against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Fifty 410, and every provider that outranks it is listed on the Fifty 410 alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Fifty 410's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Fifty 410's site. Not medical advice; see our disclosure.

← Back to all rankings